In STEP-1 (N=1,961), participants on semaglutide 2.4 mg achieved 14.9% mean body weight loss at 68 weeks compared to 2.4% with placebo [9] If applicable, documentation of failed step therapy with dates, doses, and reasons for discontinuation External Review If BCBSNC upholds the denial on internal appeal, North Carolina law entitles you to an independent external review through the NC Department of Insurance
A recent pilot study revealed that both PWS and obese patients (n=8 and 11, respectively) who were administered a single 10-g exenatide injection or placebo in a single-blinded, crossover design showed increased satiety, lowered glucose level, and insulinotropic effects [8]
are obese, of whom approximately 10% are severely obese
If you're taking a GLP-1 for type 2 diabetes, try to eat nutrient-dense foods such as lean protein, high-fiber carbohydrates, and whole fruits
En god plattform tilbyr flere kjente alternativer, men uansett metode er det trygg hndtering av persondata, solide krypteringsrutiner og tydelige behandlingsvinduer som skaper tillit